Showing results (91-100 of 2,363) with videos related to
Sort By:
Pageof 237
Vaccine|December 15, 2015
Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferretsAndrew J Broadbent, Celia P Santos, Amanda Anafu, et al.Frontiers of Medicine|January 21, 2018
Innate and adaptive T cells in influenza diseaseSimone Nüssing, Sneha Sant, Marios Koutsakos, et al.Clinical and Vaccine Immunology : CVI|March 21, 2014
Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virusChristopher D O'Donnell, Amber Wright, Leatrice Vogel, et al.Virology|April 23, 2003
Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccineRick A Bright, Ted M Ross, Kanta Subbarao, et al.The Journal of Infectious Diseases|March 29, 2002
Molecular epidemiology of influenza A(H3N2) virus reinfectionsCatherine B Smith, Nancy J Cox, Kanta Subbarao, et al.Journal of Virology|June 12, 2010
An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in miceYuk-Fai Lau, Lay-Hoon Tang, Amber W McCall, et al.Journal of Virology|December 15, 2004
Severe acute respiratory syndrome coronavirus infection of golden Syrian hamstersAnjeanette Roberts, Leatrice Vogel, Jeannette Guarner, et al.Vaccine|March 8, 2011
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adultsKawsar R Talaat, Ruth A Karron, Catherine J Luke, et al.Biofactors (Oxford, England)|June 18, 2024
The flavonoid quercetin decreases ACE2 and TMPRSS2 expression but not SARS-CoV-2 infection in cultured human lung cellsMichael James Houghton, Eglantine Balland, Matthew James Gartner, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 30, 2017
Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope?Aeron Hurt, Naomi Komadina, Yi-Mo Deng, et al.Pageof 237